Skip to content
10-Q

Quarterly Report

Bellicum Pharmaceuticals, Inc.

0001628280-23-038953

← back to feed
Filed
Nov 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 9, 2023 9.72M sh
Shares Diluted Q3 2023 · Sep 30, 2023 30.9M sh
Shares Diluted Q3 2023 · Sep 30, 2023 30.86M sh
Shares Diluted Q3 2023 · Sep 30, 2022 30.83M sh
Shares Diluted Q3 2023 · Sep 30, 2022 30.83M sh
Capex Q3 2023 · Sep 30, 2023 $4K
Capex Q3 2023 · Sep 30, 2022 $14K
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$15.94M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$18.87M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $5.91M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $21.84M
Stockholders Equity Q3 2023 · Sep 30, 2023 −$27.01M
Stockholders Equity Q3 2023 · Jun 30, 2023 −$21.84M
Stockholders Equity Q3 2023 · Mar 31, 2023 −$10.02M
Stockholders Equity Q3 2023 · Dec 31, 2022 $2.02M
Stockholders Equity Q3 2023 · Sep 30, 2022 $7.5M
Stockholders Equity Q3 2023 · Jun 30, 2022 $14.04M
Stockholders Equity Q3 2023 · Mar 31, 2022 $17.43M
Stockholders Equity Q3 2023 · Dec 31, 2021 $24.4M
Total Liabilities Q3 2023 · Sep 30, 2023 $2.25M
Total Liabilities Q3 2023 · Dec 31, 2022 $3.77M
Current Assets Q3 2023 · Sep 30, 2023 $6.85M
Current Assets Q3 2023 · Dec 31, 2022 $23.8M
Total Assets Q3 2023 · Sep 30, 2023 $6.85M
Total Assets Q3 2023 · Dec 31, 2022 $23.82M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.02
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.52
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.23
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.61
Eps Basic Q3 2023 · Sep 30, 2023 −$0.02
Eps Basic Q3 2023 · Sep 30, 2023 −$0.52
Eps Basic Q3 2023 · Sep 30, 2022 −$0.23
Eps Basic Q3 2023 · Sep 30, 2022 −$0.61
Sga Expense Q3 2023 · Sep 30, 2023 $1.51M
Sga Expense Q3 2023 · Sep 30, 2023 $5.21M
Sga Expense Q3 2023 · Sep 30, 2022 $1.32M
Sga Expense Q3 2023 · Sep 30, 2022 $4.22M
Rd Expense Q3 2023 · Sep 30, 2023 $263K
Rd Expense Q3 2023 · Sep 30, 2023 $12.29M
Rd Expense Q3 2023 · Sep 30, 2022 $6.85M
Rd Expense Q3 2023 · Sep 30, 2022 $16.43M
Net Income Q3 2023 · Sep 30, 2023 −$763K
Net Income Q3 2023 · Sep 30, 2023 −$16.18M
Net Income Q3 2023 · Sep 30, 2022 −$7.21M
Net Income Q3 2023 · Sep 30, 2022 −$18.78M
Operating Income Q3 2023 · Sep 30, 2023 −$773K
Operating Income Q3 2023 · Sep 30, 2023 −$16.49M
Operating Income Q3 2023 · Sep 30, 2022 −$7.17M
Operating Income Q3 2023 · Sep 30, 2022 −$19.64M
Revenue Q3 2023 · Sep 30, 2023 $1M
Revenue Q3 2023 · Sep 30, 2023 $1.01M
Revenue Q3 2023 · Mar 31, 2023 $8K
Revenue Q3 2023 · Sep 30, 2022 $1M
Revenue Q3 2023 · Sep 30, 2022 $1M